Pembrolizumab vs Spironolactone

## Pembrolizumab vs Spironolactone: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Spironolactone**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Spironolactone**: Mineralocorticoid receptor antagonist.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Spironolactone — 1.4 hours.

## Chemical Properties

**Molecular Formula**: Pembrolizumab — N/A; Spironolactone — C24H32O4S.

**Molecular Weight**: Pembrolizumab — N/A; Spironolactone — 416.5740 g/mol.

**Type**: Pembrolizumab — Antibody; Spironolactone — Small molecule.